US 2019/0240182 A1Published application

Methods of treating mixed dyslipidemia

AssigneeAmarin Pharmaceuticals Ireland Limited

InventorsIan Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Mehar Manku

Life of this patent

Estimating the term…

Abstract

The present disclosure relates to, inter alia, methods of treating cardiovascular-related disease.

Claims13

Dependent claims

A method of treating or preventing a cardiovascular disease in a subject having diabetes or at risk of developing diabetes, the method comprising administering to the subject a pharmaceutical composition comprising about 4 g of eicosapentaenoic acid ethyl ester per day.

Dependencies are inferred from the claim text.

Facts

Application: 16/389,317Filed 19 Apr 2019
Priority: 29 Apr 2009
Published: 8 Aug 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification30 codes

A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A61K 9/127
Dispersions; Emulsions: synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
A61K 9/48
Medicinal preparations characterised by special physical form: preparations in capsules, e.g. of gelatin, of chocolate
A61K 9/4858
Filling excipients; Inactive ingredients: organic compounds

Family

Application61/173,759Us provisional application · filed 29 Apr 2009
Application13/266,085Continuation · filed 30 Jan 2012
Application13/417,899Continuation · filed 12 Mar 2012
Application13/540,319Continuation · filed 2 Jul 2012
Application13/898,447Continuation · filed 20 May 2013
Application14/175,602Continuation · filed 7 Feb 2014
Application14/704,329Continuation · filed 5 May 2015
Application15/725,617Continuation · filed 5 Oct 2017
Application16/284,543Continuation · filed 25 Feb 2019
Application16/389,317Continuation
US 10,265,287 B2Related patent
US 10,624,870 B2Related patent
US 10,792,267 B2Related patent
US 11,033,523 B2Related patent
US 2012/0121698 A1Published application
US 2012/0302589 A1Published application
US 2013/0005757 A1Published application
US 2013/0253030 A1Published application
US 2014/0154310 A1Published application
US 2015/0231102 A1Published application
US 2018/0042880 A1Published application
US 2019/0183831 A1Published application
US 8,563,608 B2Related patent
US 8,618,166 B2Related patent
US 8,691,871 B2Related patent
US 9,056,088 B2Related patent
US 9,855,237 B2Related patent
US 2019/0240182 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Facts

Application

16/389,317Filed 19 Apr 2019

Priority

29 Apr 2009

Published

8 Aug 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification30 codes

A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A61K 9/127
Dispersions; Emulsions: synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
A61K 9/48
Medicinal preparations characterised by special physical form: preparations in capsules, e.g. of gelatin, of chocolate
A61K 9/4858
Filling excipients; Inactive ingredients: organic compounds

Family

Application61/173,759Us provisional application · filed 29 Apr 2009

Application13/266,085Continuation · filed 30 Jan 2012

Application13/417,899Continuation · filed 12 Mar 2012

Application13/540,319Continuation · filed 2 Jul 2012

Application13/898,447Continuation · filed 20 May 2013

Application14/175,602Continuation · filed 7 Feb 2014

Application14/704,329Continuation · filed 5 May 2015

Application15/725,617Continuation · filed 5 Oct 2017

Application16/284,543Continuation · filed 25 Feb 2019

Application16/389,317Continuation

US 10,265,287 B2Related patent